169 related articles for article (PubMed ID: 37894371)
1. Niosomal Delivery of Celecoxib and Metformin for Targeted Breast Cancer Treatment.
Basheer HA; Alhusban MA; Zaid Alkilani A; Alshishani A; Elsalem L; Afarinkia K
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894371
[TBL] [Abstract][Full Text] [Related]
2. Co-encapsulation of hydrophilic and hydrophobic drugs into niosomal nanocarrier for enhanced breast cancer therapy: In silico and in vitro studies.
Amiri S; Pashizeh F; Moeinabadi-Bidgoli K; Eyvazi Y; Akbari T; Salehi Moghaddam Z; Eskandarisani M; Farahmand F; Hafezi Y; Nouri Jevinani H; Seif M; Mousavi-Niri N; Chiani M; Tavakkoli Yaraki M
Environ Res; 2023 Dec; 239(Pt 2):117292. PubMed ID: 37806480
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of curcumin-Cu and curcumin-Ag nanoparticle loaded niosome: Enhanced antibacterial and anti-biofilm activities.
Targhi AA; Moammeri A; Jamshidifar E; Abbaspour K; Sadeghi S; Lamakani L; Akbarzadeh I
Bioorg Chem; 2021 Oct; 115():105116. PubMed ID: 34333420
[TBL] [Abstract][Full Text] [Related]
4. Advanced nano-therapeutic delivery of metformin: potential anti-cancer effect against human colon cancer cells through inhibition of GPR75 expression.
Ghorbanzadeh F; Jafari-Gharabaghlou D; Dashti MR; Hashemi M; Zarghami N
Med Oncol; 2023 Jul; 40(9):255. PubMed ID: 37515667
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of artemisinin and metformin via PEGylated niosomal nanoparticles: potential anti-cancer effect in treatment of lung cancer cells.
Abdulkareem SJ; Jafari-Gharabaghlou D; Farhoudi-Sefidan-Jadid M; Salmani-Javan E; Toroghi F; Zarghami N
Daru; 2024 Jun; 32(1):133-144. PubMed ID: 38168007
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of oxaliplatin via folate-decorated niosomal nanoparticles potentiates resistance reversion of colon cancer cells.
Abdulzehra S; Jafari-Gharabaghlou D; Zarghami N
Heliyon; 2023 Nov; 9(11):e21400. PubMed ID: 37954331
[TBL] [Abstract][Full Text] [Related]
7. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.
Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M
Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236
[TBL] [Abstract][Full Text] [Related]
8. Niosomal delivery of simvastatin to MDA-MB-231 cancer cells.
Akbarzadeh I; Saremi Poor A; Yaghmaei S; Norouzian D; Noorbazargan H; Saffar S; Ahangari Cohan R; Bakhshandeh H
Drug Dev Ind Pharm; 2020 Sep; 46(9):1535-1549. PubMed ID: 32808813
[TBL] [Abstract][Full Text] [Related]
9. Formulation Development and In vitro-Ex vivo Assessment of Simvastatin Niosomal Buccal Films.
Beeravelli S; Akondi V; Nimmathota M
Recent Pat Nanotechnol; 2022; 16(3):235-249. PubMed ID: 34061010
[TBL] [Abstract][Full Text] [Related]
10. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
[TBL] [Abstract][Full Text] [Related]
11. Encapsulation of Leflunomide (LFD) in a novel niosomal formulation facilitated its delivery to THP-1 monocytic cells and enhanced Aryl hydrocarbon receptor (AhR) nuclear translocation and activation.
Hasani M; Sani NA; Khodabakhshi B; Arabi MS; Mohammadi S; Yazdani Y
Daru; 2019 Dec; 27(2):635-644. PubMed ID: 31432467
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis Induction, Cell Cycle Arrest and Anti-Cancer Potential of Tamoxifen-Curcumin Loaded Niosomes Against MCF-7 Cancer Cells.
Fatemizadeh M; Tafvizi F; Shamsi F; Amiri S; Farajzadeh A; Akbarzadeh I
Iran J Pathol; 2022; 17(2):183-190. PubMed ID: 35463725
[TBL] [Abstract][Full Text] [Related]
13. Niosomal encapsulation of ethambutol hydrochloride for increasing its efficacy and safety.
El-Ridy MS; Yehia SA; Kassem MA; Mostafa DM; Nasr EA; Asfour MH
Drug Deliv; 2015 Jan; 22(1):21-36. PubMed ID: 24359403
[TBL] [Abstract][Full Text] [Related]
14. Niosomal gel for site-specific sustained delivery of anti-arthritic drug: in vitro-in vivo evaluation.
Kaur K; Jain S; Sapra B; Tiwary AK
Curr Drug Deliv; 2007 Oct; 4(4):276-82. PubMed ID: 17979648
[TBL] [Abstract][Full Text] [Related]
15. Sorbitan ester niosomes for topical delivery of rofecoxib.
Das MK; Palei NN
Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
[TBL] [Abstract][Full Text] [Related]
16. Design and optimization various formulations of PEGylated niosomal nanoparticles loaded with phytochemical agents: potential anti-cancer effects against human lung cancer cells.
Shahbazi R; Jafari-Gharabaghlou D; Mirjafary Z; Saeidian H; Zarghami N
Pharmacol Rep; 2023 Apr; 75(2):442-455. PubMed ID: 36859742
[TBL] [Abstract][Full Text] [Related]
17. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
[TBL] [Abstract][Full Text] [Related]
18. Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system.
Hasan AA; Madkor H; Wageh S
Drug Deliv; 2013; 20(3-4):120-6. PubMed ID: 23651102
[TBL] [Abstract][Full Text] [Related]
19. Formulation optimization,
Aldawsari MF; Khafagy ES; Moglad EH; Selim Abu Lila A
Saudi Pharm J; 2023 Sep; 31(9):101734. PubMed ID: 37649675
[TBL] [Abstract][Full Text] [Related]
20. Fabricating niosomal-PEG nanoparticles co-loaded with metformin and silibinin for effective treatment of human lung cancer cells.
Salmani-Javan E; Jafari-Gharabaghlou D; Bonabi E; Zarghami N
Front Oncol; 2023; 13():1193708. PubMed ID: 37664043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]